89bio, Inc. - Common Stock (ETNB)

Q4 2023 13F Holders as of 12/31/2023

Type / Class
Equity / Common Stock
Shares outstanding
149M
Number of holders
3
Total 13F shares, excl. options
539K
Shares change
+456K
Total reported value, excl. options
$6.04M
Value change
+$5.11M
Number of buys
3
Price
$11.17

Significant Holders of 89bio, Inc. - Common Stock (ETNB) as of Q4 2023

3 filings reported holding ETNB - 89bio, Inc. - Common Stock as of Q4 2023.
89bio, Inc. - Common Stock (ETNB) has 3 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 539K shares of 149M outstanding shares and own 0.36% of the company stock.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (11.4M shares), JANUS HENDERSON GROUP PLC (8.92M shares), RTW INVESTMENTS, LP (5.58M shares), BlackRock Inc. (5.45M shares), STATE STREET CORP (5.4M shares), SUVRETTA CAPITAL MANAGEMENT, LLC (4.89M shares), Pictet Asset Management Holding SA (4.56M shares), VANGUARD GROUP INC (4.31M shares), BVF INC/IL (4.05M shares), and Holocene Advisors, LP (3.49M shares).
This table shows the top 3 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.